Drug-labels.com

Q-Terbinafine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
250 mg

Patient Medication Information: uses, side effects, how to take - Q-Terbinafine

ABOUT THIS MEDICATION

What the medication is used for:

Q-TERBINAFINE tablet is used to treat fungal infections of skin, fingernails and toenails:

  • Q-TERBINAFINE tablets are used to treat fungal

    infections of the nail (toes, fingers) and may be used for certain fungal skin infections that do not respond to topical treatment.

Consult your doctor to confirm which type of fungal skin infection you have. Your doctor can determine if Q-TERBINAFINE is the right treatment for you.

The treatment should only be taken as prescribed by your doctor. Some evidence of infection may still be present at the end of treatment. This will gradually diminish.

What it does

Terbinafine belongs to the group of medicines called antifungal agents and is used to treat fungal infections of the skin, hair and nails. When taken by mouth, terbinafine reaches the site of infection in concentrations strong enough to kill the fungus or stop it growing.

When it should not be used:

Do not use Q-TERBINAFINE if you are allergic to terbinafine (the active antifungal ingredient) or any of the ingredients in the formulation (See What the nonmedicinal ingredients are).

If you think you may be allergic, ask your doctor for advice.

Do not take Q-TERBINAFINE:

  • If you have or had any liver problems.
  • If you have any kidney problems.

Important information about some of the ingredients

What the medicinal ingredient is:

terbinafine hydrochloride

What the non-medicinal ingredients are:

Tablets: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, talc.

What dosage forms it comes in:

250 mg Tablets

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions Rarely terbinafine hydrochloride tablets can cause liver problems, in very rare cases the liver problems can be serious such as liver failure, some leading to death or liver transplant.

Stop taking Q-TERBINAFINE tablets and consult your doctor immediately should you develop jaundice (yellowness of skin and/or eyes). See Table of Serious Side Effects.

Before you use Q-TERBINAFINE talk to your doctor if you:

  • have or have a history of any other medical problems such as liver or kidney problems, blood diseases (e.g. anemia), serious skin reactions, or alcohol abuse
  • if you have or have had liver problems, your doctor may require blood tests before and during Q-TERBINAFINE treatment to test liver function
  • are allergic to any other medicines (either prescription or non-prescription) or foods
  • are pregnant or intend to become pregnant while using Q-TERBINAFINE

  • are breast-feeding; terbinafine hydrochloride is excreted in breast milk.

Contact your doctor immediately, while taking Q-TERBINAFINE, if you develop conditions such as:

  • liver problems with symptoms such as persistent nausea, vomiting, abdominal pain, dark urine,
IMPORTANT: PLEASE READ

pale stools, fatigue, loss of appetite, yellowing of the skin and eyes

  • serious skin reactions such as blistering or

    peeling skin, blistering of the lips, eye or mouth, red/inflamed skin, hives, fever (due to skin reactions), rash (due to high white blood cell count-eosinophilia)

  • experience symptoms of lupus erythematosus

    such as thickened patches of red/silver skin (psoriasis), joint pain, muscle disorder/pain and fever blood disorder with symptoms such as weakness, unusual bleeding, bruising, sore throat or frequent infections

I

INTERACTIONS WITH THIS MEDICATION

NTERACTIONS WITH THIS MEDICATION Tablets:

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including herbal medicines, oral contraceptives (birth control pills) and non-prescription medicines. Some other medicines may interact with terbinafine hydrochloride. These include:

  • some medicines used to treat infectious diseases

    called antibiotics (e.g. rifampicin),

  • some medicines used to treat mood disorders (some

    antidepressants (such as tricyclic antidepressants, selective serotonine reuptake inhibitors including class 1A, 1B and 1C, monoamine oxidase inhibitors Type B, desipramine),

  • some medicines used to treat irregular heart rhythm

    (antiarrhythmics ( e.g. propafenone, amiodarone),

  • some medicines used to treat high blood pressure

    (e.g. beta-blockers such as metoprolol),

  • theophylline, a medicine used to relieve

    bronchospasm in asthma

  • some medicines used to treat cough (e.g.

    dextromethorphan),

  • cyclosporine, a medicine used to control your body’s

    immune system (e.g. in order to prevent rejection of transplanted organs).

  • St John’s wort [Hypericum perforatum]), a herbal

    medicine used to treat depression

Some cases of menstrual irregularities and pregnancies have been reported in patients taking terbinafine hydrochloride concomitantly with oral contraceptives; however, the rate of occurrence appears to be within the background incidence for patients taking oral contraceptives alone.

PROPER USE OF THIS MEDICATION

THIS MICATION

To help clear up your infection completely, it is very important that you keep taking this medicine for the prescribed treatment period, even if your symptoms begin to clear up or you begin to feel better after a few days. Since fungal infections may be very slow to clear up, stopping your medication too soon can cause the symptoms and the fungal infection to flare up again.

Missed Dose:

Try not to miss any doses. If you do miss a dose, take it as soon as possible. However, if it is almost time for your next dose (up to 4 hours), skip the missed dose and go back to your regular schedule. Do not double the doses and never make dose changes on your own. Take as prescribed by your doctor.

If any of the information in this leaflet causes you special concern or if you want additional information about your medicine and its use, contact your doctor or pharmacist. Always remember to follow your doctor’s instructions and have any medical tests done that your doctor may request. Keep your appointments for follow-up visits. Remember, never share your medicines with others.

Usual Adult Dose

Follow your doctor’s instructions carefully. Do not exceed the recommended dosage. If you have the impression that the effect of Q-TERBINAFINE is too strong or too weak, talk to your doctor or pharmacist.

ORAL

Adults: 250 mg once daily.

Taking Q-TERBINAFINE at the same time each day will help you remember when to take your medicine. Q-TERBINAFINE tablets can be taken on an empty stomach or after a meal.

You can take Q-TERBINAFINE tablets if you are aged 65 years and over at the same dose as younger adults. IMPORTANT: PLEASE READ

The duration of treatment varies according to the indication and the severity of infection:

TABLE I

IMPORTANT: PLEASE READ
IndicationDuration of Treatment
Onychomycosis (of fingers and toes)6 weeks to 3 months

Skin Infections

Tinea pedis (interdigital & plantar/moccasin type)

2-6 weeks
Tinea corporis, cruris2-4 weeks

If there are no signs of improvement after two weeks you should talk to your doctor.

Relief of clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If there are no signs of improvement after one week, contact your doctor.

There are other measures that you can take to help clear up your infection and make sure it does not return. For example, keep the infected areas dry and cool and change clothing that is in direct contact with the infected area(s) daily.

Overdose:

Symptoms caused by an overdose of terbinafine hydrochloride tablets include headache, nausea, stomach pain and dizziness.

Ask your doctor if you do not understand these instructions or want more information.

In case of drug overdose, contact a health care
practitioner hospital emergency department or
regional Poison Control Centre immediately, even
if there are no symptoms.

EFFECTS AND WHAT TO DO ABOUT THEM

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Q-TERBINAFINE tablets

As with all medicines, some patients taking terbinafine hydrochloride tablets may experience some unwanted effects (side effects), although not everybody gets them.

The following side effects have been reported with terbinafine tablets:

Very common (likely to affect more that 1 in every 10 patients): headache, nausea, mild abdominal pain, stomach discomfort after meal (heartburn), diarrhea, swelling or bloating (a feeling of fullness) of the abdomen, loss of appetite, skin rashes (itchy), joint pain and muscle pain.

Common (likely to affect 1 to 10 in every 100 patients): Mood disorder (depression), disturbance or loss of sense of taste, dizziness, eye disorder and tiredness. If you suffer dizziness, do not drive or operate machinery.

Uncommon (likely to affect 1 to 10 in every 1,000 patients): If you notice abnormal pale skin, mucosal lining or nail beds, unusual tiredness or weakness or breathlessness on exertion (possible signs of a disease that affects the level of red blood cells), anxiety, tingling or numbness and decreased skin sensitivity, increased sensitivity of the skin to sun, noises (e.g. hissing) in ears, fever and weight loss.

Rare (likely to affect less than 1 to 10 in every 10,000 patients): Yellow eyes or skin (liver problems) and abnormal liver function test results.

Very rare (likely to affect less than 1 in every 10,000 patients): Decrease in certain types of blood cells, lupus (an autoimmune disease), serious skin reactions, allergic reactions, psoriasis-like skin eruptions (rash with silver coloured appearance), worsening of psoriasis, skin rash with flaking or peeling and hair loss.

If you experience smell, taste, visual or hearing disorders or symptoms of depression, then stop using Q-TERBINAFINE and call your doctor.

If any of the listed side effects affect you severely, discuss this with your doctor.

Other side effects not listed above may also occur in some patients. If you notice any other side effects not mentioned in this leaflet, inform your doctor or pharmacist.

Some side effects could be serious:

  • If you develop fever, shivering, a sore throat or mouth ulcers due to infections and weakness or if you get infections more frequently or
  • If you experience difficulty in breathing, dizziness, swelling mainly of the face and throat, flushing, crampy abdominal pain and loss of consciousness or if you experience symptoms such as joint pain, stiffness, rash, fever or swollen/enlarged lymph nodes (possible signs of severe allergic reactions).
  • If you develop any skin problems such as rash, red skin, blistering of the lips, eyes or mouth, skin peeling, fever.
  • If you experience severe upper stomach pain with radiation to the back (possible signs of pancreas inflammation).
  • If you experience unexplained muscle weakness and pain or dark (red-brown) urine (possible signs of muscle necrosis).
  • SERIOUS SIDE EFFECTS, HOW OFTEN THEY
IMPORTANT: PLEASE READ
SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN
AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your doctor or

pharmacist

Stop

taking

drug and seek

immediate emergency medical

attention

Only if severeIn all cases
Rare

Liver problems, sometimes fatal with symptoms such as persistent nausea and

vomiting,

abdominal pain, fatigue, loss of appetite, dark urine, pale stools or jaundice

(yellowing of the skin and eyes).

√
Very rare

Blood

abnormalities with symptoms of sore throat, fever, mouth sore, unusual bleeding or

bruising,

√

Inflammation of the blood vessels (vasculitis) or the pancreas

(pancreatitis)

√

Serious allergic reactions

(anaphylactic or serum sickness reactions) or infections

√

Muscle

breakdown

(rhabdomyolysis)

√
Immune system disorders (lupus)√

Serious skin reactions

(blistering, peeling skin)

√

AND WHAT TO DO ABOUT THEM H

HOW TO STORE IT

OW TO STORE IT

Store at temperatures between 15°C and 30°C.

Protect tablets from light.

Keep out of reach of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

--------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E Ottawa, Ontario K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document can be found at:

www.qdpharmaceuticals.ca

The full Product Monograph for health professionals can be obtained by contacting the sponsor, QD Pharmaceuticals ULC Canada at: 1-800-661-3429.

Last revised: October 8, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02372762

Revision date stated in the text: October 8, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Q-Terbinafine

Rx or OTC
Prescription (Rx)?
DIN 02372762
Schedule(s) PRESCRIPTION
Active ingredient(s) Terbinafine (terbinafine hydrochloride) 250 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. D Dermatologicals
    1. D01 Antifungals for dermatological use
      1. D01B Antifungals for systemic use
        1. D01BA Antifungals for systemic use
          1. D01BA02 Terbinafine
Company QD PHARMACEUTICALS ULC
Current status Cancelled Post Market
Current status date August 21, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.